Fathian A, Fazlinejad N, Attar A
Int J Surg Case Rep. 2025; 127:110820.
PMID: 39787787
PMC: 11780152.
DOI: 10.1016/j.ijscr.2025.110820.
Yun J, Ryu Y, Lee Y
Front Med (Lausanne). 2024; 11:1418228.
PMID: 39610683
PMC: 11602313.
DOI: 10.3389/fmed.2024.1418228.
Uner O, Pegany R, Stiefel H, Stutzman R, Redd T
Am J Ophthalmol Case Rep. 2024; 36:102178.
PMID: 39429622
PMC: 11490681.
DOI: 10.1016/j.ajoc.2024.102178.
Nakai H, Ueda K, Kitazawa K, Fukuoka H, Inatomi T, Yokoi N
Jpn J Ophthalmol. 2024; 68(6):731-740.
PMID: 39356385
PMC: 11607001.
DOI: 10.1007/s10384-024-01111-0.
Sinha S, Ramesh P, Nishant P, Morya A, Prasad R
World J Methodol. 2024; 14(2):92267.
PMID: 38983656
PMC: 11229874.
DOI: 10.5662/wjm.v14.i2.92267.
Post-operative interventional radiotherapy (brachytherapy) in advanced ocular surface and eyelid tumors as an alternative to surgical retreatment.
Cuffaro G, Fionda B, Piccinni F, Pagliara M, Sammarco M, Blasi M
Eur J Ophthalmol. 2023; 34(4):1266-1276.
PMID: 38105586
PMC: 11295413.
DOI: 10.1177/11206721231215105.
Invasive Acantholytic Ocular Surface Squamous Neoplasia: A Rare Case.
Sharma A, Daigavane S, Bhake A
Cureus. 2023; 15(5):e39219.
PMID: 37337502
PMC: 10276922.
DOI: 10.7759/cureus.39219.
Recurrence of Primary Acquired Melanosis and Conjunctival Intraepithelial Neoplasia.
Svedberg K
Ocul Oncol Pathol. 2023; 8(4-6):236-241.
PMID: 36925733
PMC: 10013497.
DOI: 10.1159/000526985.
The Management of Ocular Surface Squamous Neoplasia (OSSN).
Yeoh C, Lee J, Lim B, Sundar G, Mehta J, Chan A
Int J Mol Sci. 2023; 24(1).
PMID: 36614155
PMC: 9821412.
DOI: 10.3390/ijms24010713.
Ocular surface squamous neoplasia in a patient following oral steroids for contralateral necrotising scleritis.
Yin G, Gendler S, Teichman J
BMJ Case Rep. 2022; 15(12).
PMID: 36521875
PMC: 9756198.
DOI: 10.1136/bcr-2022-253300.
The clinical presentation and treatment of an invasive conjunctival squamous spindle cell carcinoma.
Chen C, Wang S, Lai C, Chuang H, Lin Y, Wang J
Taiwan J Ophthalmol. 2022; 12(3):370-373.
PMID: 36248073
PMC: 9558473.
DOI: 10.4103/tjo.tjo_26_21.
Ocular Surface Squamous Neoplasia: A 12-Month Prospective Evaluation of Incidence in Waikato, New Zealand.
Hossain R, Oh J, McLintock C, Murphy C, McKelvie J
Vision (Basel). 2022; 6(3).
PMID: 35997381
PMC: 9397019.
DOI: 10.3390/vision6030050.
Recurrent Conjunctival Squamous Cell Carcinoma and Intraocular Tumor Extension after Topical Erythropoietin: A Case Report.
Feizi S, Esfandiari H
Case Rep Ophthalmol. 2022; 13(1):89-95.
PMID: 35350235
PMC: 8921966.
DOI: 10.1159/000521735.
Gamma Knife Stereotactic Radiosurgery for Conjunctival Squamous Cell Carcinoma Invading the Anterior Orbit: A Case Series.
Bata B, R Radatz M, Salvi S
Ocul Oncol Pathol. 2021; 7(3):206-214.
PMID: 34307334
PMC: 8280427.
DOI: 10.1159/000514340.
Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports.
Fagerberg P, Ramberg I, Toft P
Ocul Oncol Pathol. 2021; 7(2):77-84.
PMID: 33981690
PMC: 8077545.
DOI: 10.1159/000512029.
Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours.
Giannaccare G, Bernabei F, Angi M, Pellegrini M, Maestri A, Romano V
Cancers (Basel). 2021; 13(8).
PMID: 33923737
PMC: 8073875.
DOI: 10.3390/cancers13081933.
Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission.
Galvis V, Moreno N, Tello A, Carreno N
BMJ Case Rep. 2021; 14(2).
PMID: 33608345
PMC: 7896608.
DOI: 10.1136/bcr-2020-240994.
Ocular surface squamous neoplasia: management and outcomes.
Hllhumer R, Williams S, Michelow P
Eye (Lond). 2021; 35(6):1562-1573.
PMID: 33564137
PMC: 8169825.
DOI: 10.1038/s41433-021-01422-3.
Management of ocular surface squamous neoplasia extending up to a filtering trabeculectomy bleb.
Yadav S, Patil S, Deshpande R
Indian J Ophthalmol. 2020; 68(11):2540-2542.
PMID: 33120684
PMC: 7774159.
DOI: 10.4103/ijo.IJO_814_20.
Observational study of ocular surface squamous neoplasia: Risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa.
Hllhumer R, Williams S, Michelow P
PLoS One. 2020; 15(8):e0237453.
PMID: 32780766
PMC: 7418961.
DOI: 10.1371/journal.pone.0237453.